Research progress in the pathogenesis and treatment of gastric cardia cancer

doi:10.3877/cma.j.issn.2095-7157.2021.02.009

Abstract

Abstract:

Adenocarcinoma within about 2 cm below the junction of esophagus and stomach, is gastric cardia cancer.It has unique anatomical and histological characteristics and clinical manifestations. At present, the most effective treatment for early cardia cancer is endoscopic resection, which can significantly improve the 5-year survival rate. In order to improve the prognosis, early detection and correct diagnosis of early cardia cancer.In this review epidemiology, pathogenic factors and treatment of GCC will be summarized.

Key words: Gastric cardia cancer, Esophagogastric junction, Gastric adenocarcinoma, Early cancer

Tong Meng, Ziwen Qin, Xing Chen, Junhui Lu. Research progress in the pathogenesis and treatment of gastric cardia cancer[J]. Chinese Journal of Gastrointestinal Endoscopy(Electronic Edition), 2021, 08(02): 86-88.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhwcnjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-7157.2021.02.009

https://zhwcnjdzzz.cma-cmc.com.cn/EN/Y2021/V08/I02/86

References 36

[1]	崔超，刘成霞，贾兴芳．贲门癌研究现状及进展[J/CD]．世界最新医学信息文摘(连续型电子期刊)，2019，19(96) : 31-32.
[2]	Abdi E, Latifi-Navid S, Zahri S，et al. Risk factors predisposing to cardia gastric adenocarcinoma: Insights and new perspectives[J]. Cancer Med，2019，8(13): 6114-6126.
[3]	Huang Q, Read M, Gold JS，et al. Unraveling the identity of gastric cardiac cancer. J Dig Dis. 2020，21(12): 674-686.
[4]	Kumamoto T, Kurahashi Y, Niwa H，et al. True esophagogastric junction adenocarcinoma: background of its definition and current surgical trends[J]. Surg Today，2020，50(8): 809-814.
[5]	彭侠彪，陈万青，陈志峰，等．中国贲门癌流行概况[J/CD]．中华普通外科学文献(电子版)，2014，(2): 156-159.
[6]	Yao Q, Qi X, Xie SH. Sex difference in the incidence of cardia and non-cardia gastric cancer in the United States，1992-2014[J]. BMC Gastroenterol，2020，20(1): 418.
[7]	Colquhoun A, Arnold M, Ferlay J，et al. Global patterns of cardia and non-cardia gastric cancer incidence in 2012[J]. Gut，2015，64(12): 1881-1888.
[8]	张亚丽，宋昕，刘志才，等．性别与贲门腺癌术后患者预后相关性研究[J]．中华肿瘤防治杂志，2020，27(7): 543-548.
[9]	Karimi P, Islami F, Anandasabapathy S，et al. Gastric cancer: descriptive epidemiology，risk factors，screening，and prevention[J]. Cancer Epidemiol Biomark Prev，2014，23(5): 700-713.
[10]	Rugge M, Genta RM, Di Mario F，et al. Gastric Cancer as preventable disease[J]．Clin Gastroenterol Hepatol，2017，15(12): 1833-1843.
[11]	Lauby-Secretan B, Scoccianti C, Loomis D，et al. Body fat-ness and cancer-viewpoint of the IARC Working Group[J]. N Engl J Med，2016，375(8): 794-798.
[12]	Park Y, Colditz GA. Diabetes and adiposity: a heavy load for cancer[J]. Lancet Diabetes Endocrinol，2018，6(2): 82-83.
[13]	Avgerinos KI, Spyrou N, Mantzoros CS，et al. Obesity and cancer risk: Emerging biological mechanisms and perspectives[J]. Metabolism，2019，9(2): 121-135.
[14]	Singh S, Varayil JE, Devanna S, et al. Physical activity is associated with reduced risk of gastric cancer: a systematic review and meta-analysis[J]. Cancer Prev Res，2014，7(1): 12-22.
[15]	Shakeri R, Malekzadeh R, Etemadi A, et al. Opium: an emerging risk factor for gastric adenocarcinoma[J]. Int J Cancer，2013，133(2): 455-461.
[16]	Agudo A, Cayssials V, Bonet C, et al. Inflammatory potential of the diet and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) study[J]. Am J Clin Nutr，2018 ，107(4): 607-616.
[17]	车丽敏，杨君青，赵欣，等．消化系统肿瘤与ABO血型相关性分析[J]．现代消化及介入诊疗，2019，24(3): 295-297.
[18]	金鹏，田艳涛．从胃癌高危因素看生活方式的变革[J]．医学综述，2020，26(17): 3329-3337.
[19]	高振凯，梁述容，易鸣，等．幽门螺杆菌感染与贲门癌癌前病变的相关性分析[J]．医药前沿，2019，9(32): 27-29.
[20]	Jayalekshmi PA, Hassani S, Nandakumar A, et al. Gastric cancer risk in relation to tobacco use and alcohol drinking in Kerala, India-Karunagappally cohort study[J]. World J Gastroenterol，2015，21(44): 12676-12685.
[21]	Na HK, Lee JY. Molecular Basis of Alcohol-Related Gastric and Colon Cancer[J]. Int J Mol Sci，2017，18(6): 1116.
[22]	潘华，李婧．身体质量指数与贲门癌的相关性研究[J]．中国卫生标准管理，2018，9(22): 38-42.
[23]	江美花．环境因素、COPS2、CTSF、NT5E、TERF1 miRNA相关基因单核苷酸多态性与胃癌的关联研究[D]．福建医科大学，2017.
[24]	ZeLong Y, ZhenYu C, JianHai L，et al. Influence of Tumor Location on Lymph Node Metastasis and Survival for Early Gastric Cancer: a Population-Based Study[J]. J Gastrointest Surg，2020，24(9): 1978-1986.
[25]	黄勤，徐桂芳，樊祥山，等．早期贲门癌临床病理及内镜治疗研究进展[J]．中华消化内镜杂志，2019，36(5): 309-311.
[26]	Tan Y, Zhou B, Zhang S，et al.Submucosal Tunneling Endoscopic Resection for Gastric Submucosal Tumors: a Comparison Between Cardia and Non-cardia Location[J]. J Gastrointest Surg，2019，23 (11): 2129-2135.
[27]	Allemann P, Fournier P. Reflux Disease and Adenocarcinoma of the Esophagus and Cardia: Global Management and Surgical Treatment[J]. J Laparoendosc Adv Surg Tech A，2020，30(8): 869-874.
[28]	刘向前，孙晓霞．经腹与经胸根治术对贲门癌术后患者预后的影响[J]．临床医学研究与实践，2020，5(9): 50-51.
[29]	Kiyokawa T, Fukagawa T. Recent trends from the results of clinical trials on gastric cancer surgery[J]．Cancer Commun (Lond)，2019，39(1): 11.
[30]	骆杨，霍亮，许家亮，等．阿帕替尼联合奥沙利铂和替吉奥在局部晚期胃癌新辅助化疗中的应用效果[J]．肿瘤基础与临床，2019，32(2): 154-156.
[31]	Tsai C, Mueller A, Maubach J，et al.No Difference in Survival between Neo-Adjuvant Chemotherapy and Neo-Adjuvant Chemoradiation Therapy in Gastric Cardia Cancer Patients：A Contemporary View from the National Cancer Database[J]．Dig Surg，2020，37(3): 249-257.
[32]	王国义，梁剑峰，田锦林，等．内镜直视与X线透视下支架置入术治疗晚期食管贲门癌临床疗效比较[J]．临床外科杂志，2018，26(9): 679-682.
[33]	Wang C, Zhu GY, Lu J，et al. Efficacy of a novel fully covered radioactive stent for advanced esophageal and gastric cardia cancer: a retrospective controlled study[J]. Zhonghua Yi Xue Za Zhi，2019，99(47): 3687-3693.
[34]	Park CH, Park JC, Chung H，et al. A specific role of endoscopic ultrasonography for therapeutic decision-making in patients with gastric cardia cancer[J]. Surg Endosc，2016，30(10): 4193-4199.
[35]	Xin J, Wu Y, Wang X，et al. A transcriptomic study for identifying cardia- and non-cardia-specific gastric cancer prognostic factors using genetic algorithm-based methods[J]. J Cell Mol Med，2020，24(16): 9457-9465.
[36]	Schneider PM, Eshmuminov D, Rordorf T，et al. 18FDG-PET-CT identifies histopathological non-responders after neoadjuvant chemotherapy in locally advanced gastric and cardia cancer: cohort study[J]. BMC Cancer，2018，18(1): 548.

Please choose a citation manager

Content to export